Latest Period
Q1 2026
CUSIP: 59267L107
Latest Period
Q1 2026
Institutions Reporting
0
Shares (Excl. Options)
0
Price
$70.75
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 0 institutions filings for Q1 2026.
What is CUSIP 59267L107?
CUSIP 59267L107 identifies MTSR - METSERA, INC. - Common Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q1 2026 holders report and the ownership history table below.
Use the next link that matches the question you still need to answer about this security.
Open recent reporting periods for CUSIP 59267L107:
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Validae Health, L.P. | 12% | $346,544,669 | 13,136,644 | Christopher Whitten Bernard | 31 Mar 2025 | |||
| VANGUARD GROUP INC | 5.5% | $304,823,049 | 5,824,993 | The Vanguard Group | 30 Sep 2025 | |||
| JANUS HENDERSON GROUP PLC | 3.1% | -40% | $228,620,854 | -$148,748,091 | 3,242,849 | -39% | JANUS HENDERSON GROUP PLC | 31 Dec 2025 |
As of 31 Mar 2026, 0 institutional investors reported holding 0 shares of METSERA, INC. - Common Stock (MTSR). This represents 0% of the company’s total 104,608,032 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 0 | $0 | -$298,374 | $70.75 | 0 |
| 2025 Q4 | 8 | $564 | -$3,388,074,231 | $70.50 | 1 |
| 2025 Q3 | 64,760,626 | $3,388,897,067 | +$398,027,459 | $52.33 | 153 |
| 2025 Q2 | 61,110,674 | $1,738,613,325 | +$190,248,205 | $28.45 | 107 |
| 2025 Q1 | 54,515,246 | $1,486,157,710 | +$1,485,323,689 | $27.22 | 79 |